Bristol Myers Squibb (BMY)

R&D to Revenue

22.81%

Quarterly · Period ending:

BMY logo

BMY R&D to Revenue

Latest reported22.81%
BMY Quarterly R&D/Revenue (0.00% → 22.81%)
High-resolution chart · PNG

BMY r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D to Revenue — Quarterly
Period endingR&D to Revenue
22.8089%
23.0568%
20.683%
20.684%
21.0286%
20.15%
25.8548%
19.963%
23.7603%
22.7139%
21.591%
20.445%
20.114%
20.4728%
22.006%
21.5546%
19.5255%
19.4025%
21.7522%
25.6366%
21.1741%
20.0397%
33.8815%
23.7097%
24.8988%
22.0017%
26.2681%
22.9399%
21.1223%
22.7703%
23.104%
22.4917%
42.6893%
24.0709%
35.2542%
29.7107%
32.64%
26.4354%
26.7023%
23.1207%
25.9906%
25.8711%
44.6933%
27.8201%
44.5832%
25.1423%
27.9239%
25.0701%
36.4104%
24.8229%
21.5492%
21.968%
23.4931%
24.2756%
25.8172%
25.455%
21.652%
17.311%
18.4818%
18.2039%
16.9856%
18.659%
19.7613%
17.1738%
17.2399%
18.9307%
36.1739%
14.9444%
15.0632%
18.1057%
21.7756%
15.8736%
15.8755%
15.0936%
17.7769%
15.8812%
15.3206%
17.672%
19.4873%
18.1993%
15.192%
16.0393%
15.4413%
14.034%
13.2747%
14.4086%
20.2573%
11.3322%
11.5101%
11.2527%
12.1678%
10.5865%
10.3721%
10.0828%
13.6421%
11.7919%
13.0027%
12.2979%
14.3885%
10.2256%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.